csg-admin-2019

November 5, 2024

KITHER BIOTECH ANNOUNCES PHASE 1 CLINICAL STUDY OF KIT2014, A NOVEL INHALED PEPTIDE THERAPY FOR CYSTIC FIBROSIS

• Study to evaluate the safety and tolerability of KIT2014, an inhaled peptide therapy designed to enhance Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) function, act […]
May 9, 2024

Aardvark Therapeutics Announces $85 Million Oversubscribed Series C Financing

Series C financing led by Decheng Capital and supported by a syndicate of new and existing investors including Cormorant Asset Management, Surveyor Capital, SymBiosis, Tetragon […]
April 4, 2023

We need more than brain injury awareness: We need new treatment

Advocates push ‘all hands to the pump’ approach in push for more resources By Rep. Bill Pascrell Jr. and Vishal Bansal- March 6, 2023 Rep. […]
November 23, 2022

Why Are We Failing Veterans Who Bravely Served Our Country?

Since 9/11, four times as many US service members have died by suicide as have died in combat. By Frank Larkin and Michael Wyand – […]